Arrowhead Pharmaceuticals Inc. (ARWR)
Market Closed
12 Jun, 20:00
$
74. 52
+0.11
+0.1478%
$
10.4B Market Cap
- P/E Ratio
- Div Yield
1.17M Volume
-1.55 Eps
$ 74.41
Previous Close Investors:
Want to track ARWR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arrowhead Pharmaceuticals Inc. (ARWR) Statistics
Valuation metrics
Market Cap 10.4B
Enterprise value 11.48B
Trailing P/E (ttm) -34.59
Forward P/E -17.29
PEG ratio 0
Price/Sales (ttm) 16.55
Price/Book (mrq) 16.95
Enterprise Value/Revenue 18.46
Enterprise Value/EBITDA -85.37
Overview
Shares outstanding 140.57M
Float 122.81M
Shares short 12.94M
% Held by insiders 0.04%
% Held by institutions 0.89%
Average volume (10 days) 1.25M
Average volume (90 days) 2.03M
Price summary
52-Week low 14.3
52-Week high 82.26
Beta 1.29
50-Day moving average 74.77
200-Day moving average 65.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 17 Nov 2011
Financials
Fiscal year
Fiscal year ends 30 Sep 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.48%
Operating margin -0.36%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.55%
Income Statement
Revenue (ttm) 622.01M
Revenue per share (ttm) 4.37
Quarterly revenue growth (yoy) -0.86%
Gross profit (ttm) 622.01M
EBITDA 164.82M
Net income to common (ttm) -300.91M
Diluted EPS (ttm) -2.11
Quarterly earnings growth (yoy) -0.86%
Balance Sheet
Total cash (mrq) 1.78B
Total cash per share (mrq) 12.53
Total debt (mrq) 1.38B
Total Debt/Equity (mrq) 2.24
Current ratio (mrq) 6.23%
Book value per share (mrq) 4.21
Cash Flow
Cash flow statement -36.31M
Levered free cash flow (LFCF) -46.12M
